An Integrated Cell-Death Program Defines Aggressive Prostate Cancer by Coupling Ezrin to the Hippo–YAP/TAZ Axis
The AEN score is a robust prognostic tool linking PCD activity to PCa aggressiveness and immune evasion and EZR emerges as a functional effector and potential therapeutic target acting through Hippo signaling in PCa.